logo
Physician Perspectives On Prior Authorization Reform

Physician Perspectives On Prior Authorization Reform

Forbes5 hours ago

Many physicians believe prior authorization gets in the way of sound patient care. New reforms from ... More the insurance industry aim to address these challenges. Will they make a difference?
You learn a lot in medical school. About human biology, medical ethics and how to make a diagnosis. One thing they don't teach you about—but which rears its head all the time in the actual practice of medicine—is prior authorization.
Prior authorization is what is known in healthcare as a utilization management tool. Physicians submit requests to insurers, who respond with determinations about whether they will cover the proposed procedures, services, or medications before the patient receives them. The goal is to steer customers toward modalities of care that have been demonstrated to produce the best outcomes at a reasonable cost.
During office hours, between procedures, even in the middle of consults—prior authorization is something physicians have to deal with constantly.
Last week, amid scrutiny from lawmakers and regulators as well as public outrage over the practice, health insurers working with the trade association AHIP (on whose board I sit as CEO of SCAN Health Plan, a not-for-profit health insurance company) announced a set of voluntary commitments aimed at simplifying prior authorization and 'connecting patients more quickly to the care they need while minimizing administrative burdens on providers.' The commitments include faster turnaround times, greater transparency, and reduced requirements for routinely approved services. These reforms are sensible and—let's be honest—probably overdue.
But will they make a difference?
'Administrative Hurdles'
Despite its daily impact on the practice of medicine, prior authorization isn't something physicians talk about very much. So, in order to gauge how prior authorization affects their work and their patients and what effect the voluntary reforms might have, I reached out to several colleagues in different specialties to hear their stories about prior authorization. What I heard were honest reflections on their experience with the practice—and an urgent call to reimagine a system that too often gets in the way of care.
Jay Patel, an orthopedic surgeon in Orange County, CA, specializing in hip and knee replacements, describes a system that increasingly delays care for no clear reason by putting up 'administrative hurdles to surgeries that are appropriate.'
Patel notes that some payers require that he submits imaging reports in separate documents that duplicate the information contained in previously submitted medical records. 'Most of the time there's some minor piece of information they need that's already in the record, and they reflexively approve it.'
But not always. And when delays occur, he says, they disrupt care and diminish trust between patients and their doctors. 'Patients often don't understand how the process works,' he says. 'They usually think we dropped the ball because we're the person they can get ahold of.'
Patel believes the system could be improved by reducing prior authorization requirements for physicians who consistently provide appropriate care. 'Good actors should be able to request surgery and have it approved.''Delays Matter'
A Northern California interventional cardiologist I know sees firsthand how delays in care can lead to worse outcomes. 'For every test, you have to wait a week for authorization,' he says. 'And when it comes to cardiac conditions, delays matter.'
He laments that the delays can push patients to seek emergency care when they experience shortness of breath or other symptoms. 'Put yourself in their shoes. When your heart hurts you may be afraid you will die.' He says that some of his patients have decided to go to the emergency room rather than wait for approvals. In these cases, the patients are admitted and treated as inpatients, which he notes is ultimately more expensive for the plan, the patient and the health system in general.
The cardiologist also notes that in his field, denials are rare. Though he often has to pick up the phone to advocate for a patient, he says that in 11 years of practice, not once has a health plan denied a procedure that he's called about.
Knowing this, he wonders if artificial intelligence or other technologies could offer ways to improve the system. 'There must be ways to optimize this. If they're authorizing the procedure 99% of the time, why can't there be instant authorization?'
Internist Jonathan Dinh says insurers often use prior authorization as a 'delay tactic.' He says that in his experience, some payers intentionally make the practice burdensome, knowing that some percentage of physicians will become frustrated and give up on the time-consuming prior authorization process. 'If there's a poor clinical outcome, the health plan maintains plausible deniability. They'll say, 'We never said 'no.' We left the decision strictly up to our providers.''
As an internist and medical group leader in Southern California, Dinh believes that the efficiency of prior authorization reflects the quality of the organization itself. 'In a well-run group, 80% to 90% of requests should be auto approved,' he explains. "The primary function of prior authorization should be to ensure patients are referred to the correct in-network provider, helping them avoid unnecessary medical bills—not to act as a barrier to care."
Dinh says delegated models in which payors assign certain administrative and clinical responsibilities—like utilization management, care coordination, and prior authorization decisions—to a provider organization or medical group can reduce the friction of prior authorization. However, he cautions that this model alone isn't enough. "Delegated entities can still improperly delay or deny care. There must be safeguards—such as expedited appeal processes—to protect patients.'
Dinh also says that patients often mistakenly blame delays in seeing a specialist due to the prior authorization process when the real underlying issue is a shortage of physicians. "People often blame delays in seeing a specialist on the prior authorization process,' he says. 'But in many cases, referrals are issued promptly—the real bottleneck is a shortage of physicians. Specialists are overwhelmed and simply don't have the capacity to see patients quickly. Of course, any delay in prior authorization only makes the situation worse.'
To address the broader issue of physician shortages, Dinh and his colleagues launched a new internal medicine residency program focusing on training more primary care internists. The initiative aims to expand access to care and improve outcomes, particularly in underserved communities. 'A well-trained internist can help offset the shortage of specialists by managing complex conditions at a high level. The true value of a primary care physician emerges when a patient's care requires coordination across multiple specialties. The ability to lead multidisciplinary care while keeping the patient and their family informed is what ultimately drives the best clinical outcomes and enhances patient satisfaction.'
A Starting Point
When a draft of AHIP's plan initially crossed my desk, I was skeptical. Voluntary reform isn't something that necessarily has a great track record in healthcare. And yet more than 50 plans (including my own) that provide coverage to tens of millions of Americans have signed on and made a public commitment to reform.
After speaking to my physician colleagues and hearing their earnest frustrations, there's no doubt in my mind that the system needs reform and the association's proposals—which are not insubstantial and would address many of the problems —are a great place to start.
After all, none of the physicians I spoke to are asking for a blank check. They're asking for a system that trusts their judgment, respects their time, and puts patients first. Reforming prior authorization isn't just about efficiency.
It's about dignity—restoring it to the people who give care, and the people who need it—and AHIP's plan, acknowledging some of the challenges my physician colleagues face every day, is a meaningful step in the right direction.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tool Predicts if Seniors with Cancer Can Stay Home Post Op
Tool Predicts if Seniors with Cancer Can Stay Home Post Op

Medscape

time23 minutes ago

  • Medscape

Tool Predicts if Seniors with Cancer Can Stay Home Post Op

TOPLINE: A novel predictive model named STAYHOME effectively estimated the risk of losing the ability to live at home among older adults after cancer surgery, demonstrating good calibration with minimal deviation from observed risks. The model predicted a 2.4% and 3.4% risk for admission to a nursing home at 6 months and 12 months, respectively. METHODOLOGY: Older adults prioritize long-term functional independence, and the ability to return and stay at home after cancer surgery remains a key concern. However, current prognostic tools focus on short-term outcomes, lacking individualized long-term risk estimates. To estimate the risk of losing the ability to live at home post-surgery, researchers developed and internally validated a risk prediction model, named STAYHOME, among 97,353 community-dwelling older adults (median age, 76 years) who underwent cancer surgery between 2007 and 2019. The predictive model included preoperative variables such as age, sex, rural residence, previous cancer diagnosis, surgery type, frailty, receipt of home care support, receipt of neoadjuvant therapy, cancer site, and cancer stage. The primary outcome was the inability to stay at home after cancer surgery, defined as the time to admission to a nursing home, and was measured at 6 months and 12 months. TAKEAWAY: Overall, 2658 patients (2.7%) at 6 months and 3746 (3.8%) at 12 months were admitted to a nursing home post-surgery. The mean predicted risk of not staying home was 2.4% at 6 months and 3.4% at 12 months. The STAYHOME tool demonstrated a strong predictive capability, with areas under the curve of 0.76 and 0.75 for 6- and 12-month predictions, respectively. The tool also demonstrated minimal deviation from the observed risk for 6-month (0.33 percentage point on average; calibration slope, 1.27) and 12-month (0.46 percentage point on average; calibration slope, 1.17) predictions. The model's calibration was excellent for most predictors at 6 months and 12 months, with a deviation of < 0.8 percentage points from the observed probability; only age older than 85 years (1.13%), preoperative frailty (1.16%), and receipt of preoperative home care support (1.25%) exceeded the deviation of 1 percentage point at 12 months. Across risk deciles, deviations between predicted and observed probabilities were 0.1%-1.5% at 6 months and 0.1%-1.9% at 12 months, reflecting good calibration. The deviation for the slight overestimation at or above the seventh decile remained under 2% for both timepoints. IN PRACTICE: 'The STAYHOME tool demonstrated good discrimination and was well calibrated. Thus, it may be a useful tool to identify a specific group of individuals at risk of not remaining home,' the authors wrote. '[The tool] used information readily available to patients, care partners, and healthcare professionals and may be implemented to provide them with individualized risk estimates and improve surgical oncology care delivery and experience for older adults,' they concluded. SOURCE: This study, led by Julie Hallet, MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, was published online in JAMA Surgery. LIMITATIONS: The STAYHOME tool showed slightly reduced discrimination for predictor levels of preoperative frailty, preoperative home care use, receipt of neoadjuvant therapy, and having stage IV disease. The model was also less well calibrated at the extremes of the risk distribution, with a slight overestimation in higher-risk categories. DISCLOSURES: This study was funded by operating grants from the Canadian Institutes for Health Research, Ontario Cancer Research Institute, and ICES. One author reported receiving speaker fees from Ipsen, outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Associated Press

time28 minutes ago

  • Associated Press

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6 —remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. 'Oxygen therapy should be a bridge to more freedom, not more restrictions,' said a VARON CEO. 'That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives.' Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen Solutions Email: [email protected] Website: View original content to download multimedia: SOURCE Varon oxygen concentrator

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Yahoo

time33 minutes ago

  • Yahoo

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6—remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. "Oxygen therapy should be a bridge to more freedom, not more restrictions," said a VARON CEO. "That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives." Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Smart, responsive oxygen delivery Reliable battery solutions and power options Quiet, discreet operation for comfort in public spaces Lightweight builds and ergonomic designs Simple interfaces, suited for users of all ages Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen SolutionsEmail: official@ View original content to download multimedia: SOURCE Varon oxygen concentrator Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store